Tristel Share News (TSTL)

LONDON (Alliance News) - Infection prevention product maker Tristel PLC said Monday it has signed a manufacturing and marketing deal with Parker Laboratories Inc in the US.

Under the deal, Parker will manufacture Tristel's Duo chlorine dioxide foam disinfectant for the North, Central, and South American markets, and also will take on product marketing.

Parker, which Tristel said pioneered the use of gels in ultrasound, makes its products from a 95,000 square foot facility in Fairfield, New Jersey.

The deal is part of Tristel's planned expansion into the North American market, and it hopes to have US Environmental Protection Agency approval for Duo during the second half of 2018.

Chief Executive Paul Swinney said: "We are very pleased to conclude this collaboration with Parker, whose President and main shareholder we first met some fifteen years ago. The company is extremely well-known in ultrasound having been around for so many years under the long-term ownership and management of the Buchalter family.

"Our collaboration will give us the platform to access the ultrasound marketplace throughout the United States and the Americas, first with our EPA approved Duo product and in due course with our FDA approved Duo."

Tristel shares were down 0.4% on Monday at 274.00 pence each.